6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
Evidence-based guide to Zepbound (tirzepatide) dosing considerations for Black and African ancestry patients, including pharmacogenomic factors, clinical trial subgroup data, and hypertension comorbidity management.
Evidence-based guide to Zepbound (tirzepatide) dosing considerations for Hispanic and Latino patients, covering pharmacogenomic factors, clinical trial subgroup data, and practical titration guidance.
Evidence-based review of how Zepbound (tirzepatide) safety, tolerability, dosing, and pharmacokinetics differ in East Asian populations, including SURMOUNT and SURPASS-J trial data.
A deep dive into tirzepatide (Zepbound) safety, efficacy, and pharmacogenomic considerations specific to Hispanic and Latino patients, with ethnicity-stratified trial data and dosing guidance.
A detailed review of tirzepatide (Zepbound) efficacy data stratified by Black and African ancestry, including SURMOUNT-1 subgroup analysis, pharmacogenomic context, hypertension considerations, and practical dosing guidance.
Evidence-based review of how Zepbound (tirzepatide) performs in Hispanic and Latino populations, including SURMOUNT trial subgroup data, pharmacogenomic considerations, and dosing guidance.